Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Change in Account Payables (2018 - 2026)

Organogenesis Holdings has reported Change in Account Payables over the past 8 years, most recently at -$1.2 million for Q4 2025.

  • For Q4 2025, Change in Account Payables fell 132.08% year-over-year to -$1.2 million; the TTM value through Dec 2025 reached -$528000.0, up 77.74%, while the annual FY2025 figure was -$528000.0, 77.74% up from the prior year.
  • Change in Account Payables for Q4 2025 was -$1.2 million at Organogenesis Holdings, down from -$994000.0 in the prior quarter.
  • Over five years, Change in Account Payables peaked at $4.5 million in Q3 2021 and troughed at -$4.4 million in Q1 2024.
  • A 5-year average of $204950.0 and a median of -$1.1 million in 2021 define the central range for Change in Account Payables.
  • Biggest five-year swings in Change in Account Payables: skyrocketed 442.54% in 2022 and later crashed 2975.4% in 2024.
  • Year by year, Change in Account Payables stood at -$1.4 million in 2021, then crashed by 43.96% to -$2.0 million in 2022, then surged by 277.56% to $3.6 million in 2023, then grew by 2.73% to $3.6 million in 2024, then crashed by 132.08% to -$1.2 million in 2025.
  • Business Quant data shows Change in Account Payables for ORGO at -$1.2 million in Q4 2025, -$994000.0 in Q3 2025, and $4.1 million in Q2 2025.